Literature DB >> 1521653

Randomized, prospective comparison of luteal leuprolide acetate and gonadotropins versus clomiphene citrate and gonadotropins in 408 first cycles of in vitro fertilization.

I S Tummon1, S A Daniel, B R Kaplan, J A Nisker, A A Yuzpe.   

Abstract

OBJECTIVE: To compare luteal phase leuprolide acetate (LA) initiated pituitary down regulation followed by human menopausal gonadotropins (hMG) versus clomiphene citrate (CC) and hMG for follicular recruitment and oocyte maturation before in vitro fertilization (IVF).
DESIGN: Randomized, prospective comparison in first cycles of IVF.
SETTING: University Hospital, a tertiary referral center offering assisted reproductive technologies. PARTICIPANTS: Participants were couples undergoing their first ever cycle of IVF and consenting to participation in the trial.
RESULTS: Luteal phase initiated LA/hMG was associated with a lower probability of cycle cancellation, improved folliculogenesis, and a higher probability of embryo transfer (ET) compared with CC/hMG alone. Implantation rates were not different.
CONCLUSION: A higher rate of ET with LA/hMG suggests that gonadotropin-releasing hormone agonist for the induction of folliculogenesis before IVF may be appropriate.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1521653

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  17 in total

1.  Confounding variables affecting in vitro fertilization success: a decade of experience.

Authors:  M Alsalili; A A Yuzpe; I S Tummon; J Parker; J S Martin; J A Nisker; S A Daniel
Journal:  J Assist Reprod Genet       Date:  1995-02       Impact factor: 3.412

2.  Serum progesterone concentration on day of embryo transfer in donor oocyte cycles.

Authors:  Paula C Brady; Daniel J Kaser; Elizabeth S Ginsburg; Rachel K Ashby; Stacey A Missmer; Katharine F Correia; Catherine Racowsky
Journal:  J Assist Reprod Genet       Date:  2014-03-12       Impact factor: 3.412

3.  The association between quality of supernumerary embryos in a cohort and implantation potential of the transferred blastocyst.

Authors:  Phillip A Romanski; Randi H Goldman; Leslie V Farland; Serene S Srouji; Catherine Racowsky
Journal:  J Assist Reprod Genet       Date:  2018-07-05       Impact factor: 3.412

4.  Abnormal human chorionic gonadotropin (hCG) trends after transfer of multiple embryos resulting in viable singleton pregnancies.

Authors:  Paula C Brady; Leslie V Farland; Stacey A Missmer; Catherine Racowsky; Janis H Fox
Journal:  J Assist Reprod Genet       Date:  2017-12-19       Impact factor: 3.412

Review 5.  Evaluation and treatment of low responders in assisted reproductive technology: a challenge to meet.

Authors:  S J Fasouliotis; A Simon; N Laufer
Journal:  J Assist Reprod Genet       Date:  2000-08       Impact factor: 3.412

6.  Clinical predictors of failing one dose of methotrexate for ectopic pregnancy after in vitro fertilization.

Authors:  Paula C Brady; Stacey A Missmer; Leslie V Farland; Elizabeth S Ginsburg
Journal:  J Assist Reprod Genet       Date:  2017-01-05       Impact factor: 3.412

7.  Comparison between a single dose of goserelin (depot) and multiple daily doses of leuprolide acetate for pituitary suppression in IVF treatment: a clinical endocrinological study of the ovarian response.

Authors:  Selmo Geber; Liana Sales; Marcos A C Sampaio
Journal:  J Assist Reprod Genet       Date:  2002-07       Impact factor: 3.412

8.  Clomiphene citrate and hMG: an alternative stimulation protocol for selected failed in vitro fertilization patients.

Authors:  C A Benadiva; O Davis; I Kligman; H C Liu; Z Rosenwaks
Journal:  J Assist Reprod Genet       Date:  1995-01       Impact factor: 3.412

Review 9.  Leuprorelin. A review of its pharmacology and therapeutic use in prostatic cancer, endometriosis and other sex hormone-related disorders.

Authors:  G L Plosker; R N Brogden
Journal:  Drugs       Date:  1994-12       Impact factor: 9.546

Review 10.  Gonadotrophin-releasing hormone agonists. A guide to use and selection.

Authors:  M Filicori
Journal:  Drugs       Date:  1994-07       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.